TRACON Pharmaceuticals Announces $8.8 Million Registered Direct Offering
SAN DIEGO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Year: 2020
Eyesight Max Reviews – Best Vision Loss Supplement? – Product Review by Mike Vaughn
Eyesight Max is a supplement that supports your vision, no matter what age you are and no matter how bad...
Inspire Medical Systems, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Option Care Health to Participate in Upcoming Virtual Investor Conference
BANNOCKBURN, Ill., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest...
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking...
Kiniksa Announces Data from U.S. Investigator-Initiated Study of Mavrilimumab in Severe COVID-19 Pneumonia and Hyperinflammation
- Early signal of efficacy with trends toward lower mortality and shorter duration of mechanical ventilation in patients treated with...
SCYNEXIS Announces Closing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously...
Novus Therapeutics Announces Results of Special Meeting of Stockholders
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused...
Carrot Enters Global Market for Tobacco Cessation with CE Mark Certification for its Breath Sensor
Clinically Proven to Increase the Motivation to Quit, the Company’s Device is the First Ever FDA-Cleared Breath Sensor for Consumer...
Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures
- Strategic investment from single biotech-focused institutional investor - - Enables clinical development of both fadraciclib and CYC140 in hematological...
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
RenovaCare 2021 Outlook RenovaCare Discusses 2020 Highlights and Provides 2021 Outlook RenovaCare Chairman & CEO, Alan L. Rubino Alan L....
Vaxil Retains Investor Engagement and Marketing Firm
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 22, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO...
Salarius Pharmaceuticals to Participate in Biotech Showcase Digital and BIO @ JPM During “J.P. Morgan Week 2021”
HOUSTON, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company developing potential new medicines for patients...
Ocugen and Bharat Biotech to Co-Develop COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market
Companies will co-develop inactivated vaccine candidate, COVAXIN™, to prevent COVID-19 infection in the US Builds upon the promising safety and...
Resverlogix Announces Apabetalone Treatment Prior to SARS-CoV-2 (COVID-19) Exposure Significantly Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
Latest publication confirms BET inhibitors reduce the levels of critical receptors used by SARS-CoV-2 (COVID-19) to gain entry into cells,...
KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder
CELEBRATION, Fla., Dec. 22, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery...
FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2
SAN FRANCISCO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced dosing of the first patient in the...
THC Therapeutics, Inc. Independently Tested, Patented Sanitizing Cannabis Dryer More Relevant Than Ever
The dHydronator’s SanitiZen® technology has been proven to reduce the microbial load level of cannabis from failing laboratory testing and...
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
Beyond retinal detachment, lead candidate ONL1204 will also advance into the chronic conditions of glaucoma and dry age-related macular degeneration...
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Conference Call and Webcast To be Held Monday, December 28th, 2020 4:30 pm Eastern TimeNEW YORK, Dec. 22, 2020 (GLOBE...